Merck (MRK) Receivables - Other (2012 - 2023)
Merck (MRK) posted quarterly Receivables - Other of $473.0 million for Q1 2023, down 34.21% year-over-year from $719.0 million in Q1 2022, and down 7.44% quarter-over-quarter from $511.0 million in Q4 2022.
Merck (MRK) Receivables - Other (2012 - 2023) Analysis & Trends
Merck (MRK) has reported Receivables - Other for 6 consecutive years, with $473.0 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Receivables - Other fell 34.21% year-over-year to $473.0 million; the TTM figure through Mar 2023 stood at $473.0 million (down 34.21% YoY), while the FY2022 annual figure was $511.0 million, down 46.99% from the prior year.
- Receivables - Other eased to $473.0 million in Q1 2023 per MRK's latest filing, from $511.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.6 billion in Q2 2021 and bottomed at $473.0 million in Q1 2023.
- Historically, Receivables - Other has averaged $860.4 million across 3 years, with a median of $684.0 million in 2022.
- Annual changes were most pronounced in 2022 — Receivables - Other tumbled 59.5% — and 2023, when it plunged 34.21%.
- Merck's Receivables - Other stood at $964.0 million in 2021, then slumped by 46.99% to $511.0 million in 2022, then declined by 7.44% to $473.0 million in 2023.
- Business Quant data shows MRK's Receivables - Other at $473.0 million in Q1 2023, $511.0 million in Q4 2022, and $567.0 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.04 Bn | 633.28 Bn | 17.26 Bn |
| 2 | AbbVie | 470.61 Bn | 464.04 Bn | 12.70 Bn |
| 3 | Merck | 379.00 Bn | 371.86 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.30 Bn | 295.61 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.47 Bn | 253.57 Bn | 12.86 Bn |
| 6 | Amgen | 237.78 Bn | 223.79 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.75 Bn | 180.57 Bn | 6.22 Bn |
| 8 | Pfizer | 160.91 Bn | 149.21 Bn | 10.94 Bn |
| 9 | Gsk | 106.07 Bn | 101.90 Bn | 8.24 Bn |
| 10 | Sanofi | 55.31 Bn | 47.93 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 473.00 Mn |
| Mar 31, 2023 | 473.00 Mn |
| Dec 31, 2022 | 511.00 Mn |
| Dec 31, 2022 | 511.00 Mn |
| Sep 30, 2022 | 567.00 Mn |
| Sep 30, 2022 | 567.00 Mn |
| Jun 30, 2022 | 649.00 Mn |
| Jun 30, 2022 | 649.00 Mn |
| Mar 31, 2022 | 719.00 Mn |
| Mar 31, 2022 | 719.00 Mn |
| Dec 31, 2021 | 964.00 Mn |
| Dec 31, 2021 | 964.00 Mn |
| Sep 30, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.40 Bn |
| Jun 30, 2021 | 1.60 Bn |
| Jun 30, 2021 | 1.60 Bn |
| Dec 31, 2017 | 325.00 Mn |
| Dec 31, 2017 | 325.00 Mn |
| Dec 31, 2013 | 195.00 Mn |
| Dec 31, 2013 | 195.00 Mn |